Mouse Anti-A1BG Recombinant Antibody (CBT3169) (V2LY-0625-LY2410)

Guselnikov, S. V., & Taranin, A. V. (2019). Unraveling the LRC evolution in mammals: IGSF1 and A1BG provide the keys. Genome biology and evolution, 11(6), 1586-1601.

Bai, J., Yao, B., Wang, L., Sun, L., Chen, T., Liu, R., ... & Yang, W. (2019). lncRNA A1BG‐AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR‐216a‐5p. Journal of cellular biochemistry, 120(6), 10310-10322.

Cai, S., Zhou, Y., Pan, Y., Liu, P., Yu, K., & Chen, S. (2021). Long non-coding RNA A1BG-AS1 promotes tumorigenesis in breast cancer by sponging microRNA-485-5p and consequently increasing expression of FLOT1 expression. Human Cell, 1-15.

Gourgari, E., Gordon, S., Ma, J., Playford, M., Mehta, N., Goldman, R., & Remaley, A. (2019). 3065 A1BG and ITIH4 proteins are upregulated on HDL of youth with type 1 diabetes and correlate with glycemic control. Journal of Clinical and Translational Science, 3(s1), 31-32.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols